Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer
Jessica Caciolla(University of Bologna), Alessandra Magistrato(Scuola Internazionale Superiore di Studi Avanzati), Angela Rampa(University of Bologna), Matic Pavlin(Scuola Internazionale Superiore di Studi Avanzati), Federica Belluti(University of Bologna), Federica Simonelli(Scuola Internazionale Superiore di Studi Avanzati), Alessandra Bisi(University of Bologna), Silvia Gobbi(University of Bologna), Silvia Martini(Fondazione IRCCS Istituto Nazionale dei Tumori), Carmela Fimognari(University of Bologna), Eleonora Turrini(University of Bologna), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Angelo Spinello(University of Palermo)
Cited by 23
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
|Cancer Research|2009|363
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
|Cellular and Molecular Life Sciences|2002|274